Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Enterobacteriaceae | 18 | 2020 | 395 | 3.89 | Why? |
Bacteremia | 25 | 2020 | 1372 | 3.61 | Why? |
Enterobacteriaceae Infections | 18 | 2019 | 529 | 3.49 | Why? |
Escherichia coli Infections | 7 | 2018 | 348 | 2.15 | Why? |
beta-Lactamases | 15 | 2019 | 759 | 2.14 | Why? |
Anti-Bacterial Agents | 38 | 2021 | 10083 | 1.86 | Why? |
Gram-Negative Bacteria | 6 | 2019 | 473 | 1.85 | Why? |
Drug Resistance, Multiple, Bacterial | 15 | 2019 | 1115 | 1.70 | Why? |
Escherichia coli | 13 | 2019 | 1547 | 1.69 | Why? |
Urinary Tract Infections | 6 | 2019 | 534 | 1.68 | Why? |
Drug Resistance, Bacterial | 15 | 2021 | 1414 | 1.52 | Why? |
beta-Lactamase Inhibitors | 7 | 2019 | 104 | 1.46 | Why? |
Gram-Negative Bacterial Infections | 6 | 2019 | 398 | 1.42 | Why? |
Rectum | 4 | 2018 | 495 | 1.32 | Why? |
Carbapenem-Resistant Enterobacteriaceae | 2 | 2018 | 214 | 1.15 | Why? |
Fosfomycin | 4 | 2018 | 48 | 1.07 | Why? |
Cross Infection | 16 | 2019 | 8675 | 0.91 | Why? |
Treatment Failure | 2 | 2018 | 2106 | 0.90 | Why? |
Anti-Infective Agents | 5 | 2019 | 1766 | 0.86 | Why? |
beta-Lactam Resistance | 3 | 2017 | 150 | 0.77 | Why? |
Pneumonia, Staphylococcal | 1 | 2017 | 38 | 0.70 | Why? |
Methicillin-Resistant Staphylococcus aureus | 6 | 2019 | 711 | 0.69 | Why? |
Sepsis | 9 | 2018 | 3517 | 0.67 | Why? |
Klebsiella pneumoniae | 8 | 2019 | 658 | 0.66 | Why? |
Antimicrobial Stewardship | 4 | 2019 | 931 | 0.64 | Why? |
Blood | 1 | 2017 | 274 | 0.63 | Why? |
Microbial Sensitivity Tests | 16 | 2019 | 2886 | 0.61 | Why? |
Vagina | 1 | 2018 | 327 | 0.60 | Why? |
Staphylococcus aureus | 2 | 2019 | 844 | 0.58 | Why? |
Microbiological Techniques | 1 | 2017 | 232 | 0.57 | Why? |
Pseudomonas Infections | 2 | 2019 | 425 | 0.57 | Why? |
Prosthesis-Related Infections | 2 | 2018 | 302 | 0.56 | Why? |
Serogroup | 1 | 2017 | 510 | 0.55 | Why? |
Staphylococcal Infections | 4 | 2019 | 1099 | 0.55 | Why? |
Carbapenems | 6 | 2019 | 343 | 0.52 | Why? |
beta-Lactams | 5 | 2018 | 210 | 0.50 | Why? |
Arthroplasty, Replacement, Knee | 1 | 2018 | 363 | 0.48 | Why? |
Bacterial Proteins | 9 | 2019 | 1318 | 0.48 | Why? |
Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.48 | Why? |
Acinetobacter baumannii | 5 | 2019 | 378 | 0.47 | Why? |
Pseudomonas aeruginosa | 5 | 2019 | 652 | 0.45 | Why? |
Bacteria | 4 | 2017 | 1897 | 0.43 | Why? |
Pneumonia, Ventilator-Associated | 1 | 2018 | 861 | 0.40 | Why? |
Klebsiella Infections | 4 | 2018 | 466 | 0.38 | Why? |
Carrier State | 2 | 2018 | 2100 | 0.34 | Why? |
Clinical Decision-Making | 1 | 2021 | 3755 | 0.33 | Why? |
Intraabdominal Infections | 2 | 2017 | 90 | 0.32 | Why? |
Immunocompromised Host | 2 | 2019 | 5150 | 0.29 | Why? |
Inappropriate Prescribing | 2 | 2019 | 284 | 0.29 | Why? |
Parents | 1 | 2019 | 2758 | 0.29 | Why? |
Genotype | 1 | 2017 | 4697 | 0.28 | Why? |
Bacterial Infections | 4 | 2019 | 2229 | 0.27 | Why? |
Risk Factors | 17 | 2021 | 71621 | 0.27 | Why? |
Stenotrophomonas maltophilia | 2 | 2019 | 63 | 0.26 | Why? |
Quality Indicators, Health Care | 2 | 2019 | 580 | 0.26 | Why? |
Neutropenia | 2 | 2017 | 388 | 0.25 | Why? |
Spain | 13 | 2021 | 15545 | 0.25 | Why? |
Amoxicillin-Potassium Clavulanate Combination | 2 | 2017 | 72 | 0.25 | Why? |
Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.25 | Why? |
ROC Curve | 4 | 2021 | 6024 | 0.25 | Why? |
Humans | 77 | 2021 | 930598 | 0.24 | Why? |
Referral and Consultation | 1 | 2019 | 4816 | 0.24 | Why? |
Penicillanic Acid | 2 | 2015 | 58 | 0.23 | Why? |
Antibodies, Monoclonal, Humanized | 2 | 2020 | 9335 | 0.23 | Why? |
C-Reactive Protein | 1 | 2018 | 7972 | 0.23 | Why? |
Community-Acquired Infections | 3 | 2017 | 2328 | 0.22 | Why? |
Europe | 11 | 2019 | 12702 | 0.22 | Why? |
Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.22 | Why? |
Aged | 32 | 2021 | 215776 | 0.21 | Why? |
Minocycline | 2 | 2017 | 101 | 0.20 | Why? |
Pneumonia, Bacterial | 2 | 2017 | 843 | 0.20 | Why? |
Prospective Studies | 13 | 2020 | 43301 | 0.19 | Why? |
Uropathogenic Escherichia coli | 1 | 2018 | 10 | 0.19 | Why? |
Male | 40 | 2021 | 367725 | 0.19 | Why? |
Communicable Diseases | 3 | 2018 | 2148 | 0.19 | Why? |
Knee Prosthesis | 1 | 2018 | 40 | 0.18 | Why? |
Female | 40 | 2021 | 380317 | 0.18 | Why? |
Middle Aged | 33 | 2021 | 270681 | 0.18 | Why? |
Shock, Septic | 2 | 2019 | 1313 | 0.18 | Why? |
Hip Prosthesis | 1 | 2018 | 54 | 0.18 | Why? |
Quorum Sensing | 1 | 2017 | 26 | 0.17 | Why? |
Societies, Scientific | 2 | 2018 | 414 | 0.17 | Why? |
Cohort Studies | 9 | 2021 | 36005 | 0.17 | Why? |
Educational Technology | 1 | 2018 | 101 | 0.17 | Why? |
Thienamycins | 1 | 2017 | 72 | 0.17 | Why? |
Bacterial Outer Membrane Proteins | 1 | 2017 | 60 | 0.17 | Why? |
Aminoglycosides | 1 | 2017 | 94 | 0.17 | Why? |
Medical Laboratory Science | 1 | 2018 | 122 | 0.17 | Why? |
Health Impact Assessment | 1 | 2019 | 181 | 0.17 | Why? |
Quinolones | 1 | 2018 | 167 | 0.16 | Why? |
Preceptorship | 1 | 2018 | 115 | 0.16 | Why? |
Ceftriaxone | 1 | 2019 | 365 | 0.16 | Why? |
Perioperative Period | 1 | 2018 | 276 | 0.16 | Why? |
Bile Acids and Salts | 1 | 2017 | 91 | 0.16 | Why? |
Enterocolitis, Pseudomembranous | 1 | 2017 | 93 | 0.16 | Why? |
Livestock | 1 | 2017 | 184 | 0.16 | Why? |
Microbiology | 1 | 2018 | 134 | 0.16 | Why? |
Gram-Positive Bacteria | 1 | 2017 | 230 | 0.16 | Why? |
Aged, 80 and over | 17 | 2021 | 88759 | 0.16 | Why? |
Escherichia coli Proteins | 1 | 2017 | 168 | 0.15 | Why? |
Multilocus Sequence Typing | 1 | 2017 | 264 | 0.15 | Why? |
Prevalence | 7 | 2021 | 25773 | 0.15 | Why? |
Case-Control Studies | 4 | 2018 | 17671 | 0.15 | Why? |
Medical Records | 1 | 2018 | 513 | 0.15 | Why? |
Monte Carlo Method | 1 | 2018 | 577 | 0.15 | Why? |
Colistin | 1 | 2017 | 217 | 0.14 | Why? |
Retrospective Studies | 15 | 2021 | 105322 | 0.14 | Why? |
Publications | 1 | 2020 | 463 | 0.14 | Why? |
Meat | 1 | 2017 | 380 | 0.14 | Why? |
Hospitals | 5 | 2021 | 11793 | 0.14 | Why? |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.13 | Why? |
Fungi | 1 | 2017 | 471 | 0.13 | Why? |
Survival Analysis | 5 | 2019 | 7592 | 0.13 | Why? |
Drug Therapy, Combination | 4 | 2020 | 7268 | 0.13 | Why? |
Evidence-Based Practice | 1 | 2019 | 693 | 0.12 | Why? |
Drug Utilization | 1 | 2018 | 619 | 0.12 | Why? |
Prognosis | 8 | 2021 | 32490 | 0.12 | Why? |
Piperacillin | 2 | 2015 | 63 | 0.12 | Why? |
Hospital Mortality | 4 | 2021 | 22087 | 0.12 | Why? |
Practice Guidelines as Topic | 2 | 2018 | 15421 | 0.12 | Why? |
Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.11 | Why? |
Morbidity | 1 | 2017 | 1426 | 0.11 | Why? |
Logistic Models | 3 | 2021 | 9089 | 0.11 | Why? |
Adult | 19 | 2021 | 244371 | 0.11 | Why? |
Proportional Hazards Models | 2 | 2020 | 6543 | 0.11 | Why? |
Decision Support Techniques | 1 | 2018 | 903 | 0.11 | Why? |
Search Engine | 1 | 2018 | 628 | 0.11 | Why? |
Odds Ratio | 2 | 2019 | 5861 | 0.10 | Why? |
Infection Control | 3 | 2018 | 23131 | 0.10 | Why? |
Kinetics | 1 | 2018 | 3238 | 0.10 | Why? |
Program Evaluation | 1 | 2018 | 1929 | 0.10 | Why? |
Virulence | 1 | 2017 | 2172 | 0.10 | Why? |
Tertiary Care Centers | 2 | 2018 | 8248 | 0.10 | Why? |
Phenotype | 1 | 2021 | 4037 | 0.10 | Why? |
Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
Treatment Outcome | 7 | 2020 | 51732 | 0.09 | Why? |
Population Surveillance | 4 | 2017 | 4967 | 0.09 | Why? |
Family Characteristics | 1 | 2018 | 2551 | 0.09 | Why? |
Feces | 2 | 2018 | 4235 | 0.09 | Why? |
Gene Expression Regulation, Bacterial | 2 | 2017 | 143 | 0.08 | Why? |
Infant, Newborn | 2 | 2018 | 23105 | 0.08 | Why? |
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 1510 | 0.08 | Why? |
Patient Care | 1 | 2017 | 1664 | 0.08 | Why? |
Hospitals, Community | 1 | 2010 | 475 | 0.08 | Why? |
Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.07 | Why? |
Liver Cirrhosis | 1 | 2017 | 1810 | 0.07 | Why? |
Fluoroquinolones | 1 | 2006 | 235 | 0.07 | Why? |
Liver Diseases | 1 | 2021 | 2698 | 0.07 | Why? |
Incidence | 3 | 2019 | 25622 | 0.07 | Why? |
Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
Education, Medical, Undergraduate | 1 | 2018 | 1392 | 0.07 | Why? |
Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
Reproducibility of Results | 2 | 2018 | 11304 | 0.07 | Why? |
Cephalosporins | 1 | 2006 | 250 | 0.07 | Why? |
Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
Virulence Factors | 2 | 2017 | 338 | 0.07 | Why? |
Endocarditis, Bacterial | 1 | 2009 | 344 | 0.07 | Why? |
Disease Outbreaks | 3 | 2018 | 27595 | 0.07 | Why? |
Disease Management | 2 | 2019 | 6841 | 0.06 | Why? |
Hospitalization | 6 | 2021 | 54280 | 0.06 | Why? |
International Cooperation | 1 | 2017 | 3436 | 0.06 | Why? |
Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.06 | Why? |
Computer Simulation | 1 | 2018 | 4982 | 0.06 | Why? |
Clinical Trials as Topic | 2 | 2021 | 7330 | 0.06 | Why? |
Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
Protein Isoforms | 1 | 2002 | 347 | 0.05 | Why? |
Leptin | 1 | 2002 | 141 | 0.05 | Why? |
Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
Cross-Sectional Studies | 5 | 2018 | 53120 | 0.05 | Why? |
Vancomycin | 2 | 2017 | 328 | 0.05 | Why? |
Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
Propensity Score | 2 | 2019 | 2690 | 0.05 | Why? |
Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
Carrier Proteins | 1 | 2002 | 513 | 0.05 | Why? |
Organization and Administration | 1 | 2018 | 93 | 0.05 | Why? |
Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
Students, Medical | 1 | 2018 | 4032 | 0.05 | Why? |
Retrognathia | 1 | 2017 | 17 | 0.04 | Why? |
Genes, MDR | 1 | 2017 | 9 | 0.04 | Why? |
Type VI Secretion Systems | 1 | 2017 | 9 | 0.04 | Why? |
Receptors, Cell Surface | 1 | 2002 | 586 | 0.04 | Why? |
Time Factors | 2 | 2019 | 31397 | 0.04 | Why? |
Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
Agar | 1 | 2017 | 15 | 0.04 | Why? |
Klebsiella | 1 | 2017 | 35 | 0.04 | Why? |
Pseudomonas | 1 | 2017 | 65 | 0.04 | Why? |
Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.04 | Why? |
Gentamicins | 1 | 2017 | 76 | 0.04 | Why? |
Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
Drug Administration Routes | 1 | 2017 | 106 | 0.04 | Why? |
Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.04 | Why? |
Drug Tolerance | 1 | 2017 | 100 | 0.04 | Why? |
Clinical Medicine | 1 | 2018 | 93 | 0.04 | Why? |
Food Microbiology | 1 | 2017 | 114 | 0.04 | Why? |
Mortality | 3 | 2019 | 7132 | 0.04 | Why? |
Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
Social Media | 1 | 2018 | 5798 | 0.04 | Why? |
Genes, Bacterial | 1 | 2017 | 207 | 0.04 | Why? |
Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
Ciprofloxacin | 1 | 2017 | 130 | 0.04 | Why? |
Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.04 | Why? |
Ceftazidime | 1 | 2017 | 134 | 0.04 | Why? |
Infant | 1 | 2018 | 30274 | 0.04 | Why? |
Blood Culture | 1 | 2017 | 308 | 0.04 | Why? |
Adolescent | 8 | 2020 | 86841 | 0.04 | Why? |
Editorial Policies | 1 | 2020 | 408 | 0.04 | Why? |
Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
Glomerular Filtration Rate | 1 | 2021 | 1262 | 0.03 | Why? |
Cause of Death | 2 | 2020 | 4823 | 0.03 | Why? |
Culture Media | 1 | 2017 | 366 | 0.03 | Why? |
Public Health | 2 | 2017 | 16359 | 0.03 | Why? |
Biofilms | 1 | 2017 | 304 | 0.03 | Why? |
Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
Quality Assurance, Health Care | 1 | 2018 | 596 | 0.03 | Why? |
Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
Drug Resistance, Microbial | 1 | 2017 | 419 | 0.03 | Why? |
Patient Outcome Assessment | 1 | 2017 | 707 | 0.03 | Why? |
DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
Research Support as Topic | 1 | 2017 | 327 | 0.03 | Why? |
Critical Illness | 1 | 2016 | 17281 | 0.03 | Why? |
Bacterial Typing Techniques | 1 | 2014 | 273 | 0.03 | Why? |
Lymphocyte Activation | 1 | 2002 | 2742 | 0.03 | Why? |
Chlorhexidine | 1 | 2014 | 176 | 0.03 | Why? |
Superinfection | 1 | 2017 | 459 | 0.03 | Why? |
Intensive Care Units | 1 | 2017 | 29594 | 0.03 | Why? |
Evidence-Based Medicine | 2 | 2017 | 3228 | 0.03 | Why? |
Research Design | 2 | 2017 | 5830 | 0.03 | Why? |
Sentinel Surveillance | 1 | 2017 | 1093 | 0.02 | Why? |
Gene Expression Regulation | 1 | 2002 | 4020 | 0.02 | Why? |
Methicillin Resistance | 1 | 2009 | 77 | 0.02 | Why? |
Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
Gastrointestinal Tract | 1 | 2017 | 1113 | 0.02 | Why? |
Hospitals, University | 2 | 2015 | 4173 | 0.02 | Why? |
Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
Communicable Disease Control | 1 | 2017 | 29620 | 0.02 | Why? |
Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
Anti-Infective Agents, Local | 1 | 2014 | 520 | 0.02 | Why? |
Periodicals as Topic | 1 | 2020 | 1492 | 0.02 | Why? |
Device Removal | 1 | 2009 | 221 | 0.02 | Why? |
Catheterization | 1 | 2009 | 264 | 0.02 | Why? |
Surveys and Questionnaires | 3 | 2018 | 43792 | 0.02 | Why? |
Long-Term Care | 1 | 2018 | 2047 | 0.02 | Why? |
Chronic Disease | 1 | 2021 | 5139 | 0.02 | Why? |
Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
Risk | 1 | 2018 | 5288 | 0.02 | Why? |
Health Personnel | 1 | 2015 | 29646 | 0.02 | Why? |
T-Lymphocytes | 1 | 2002 | 6670 | 0.02 | Why? |
Curriculum | 1 | 2018 | 3083 | 0.02 | Why? |
Epidemiological Monitoring | 1 | 2017 | 3493 | 0.02 | Why? |
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
Catheterization, Central Venous | 1 | 2009 | 458 | 0.02 | Why? |
Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
Animals | 3 | 2017 | 78931 | 0.02 | Why? |
Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
Global Health | 2 | 2017 | 13911 | 0.02 | Why? |
Hematologic Neoplasms | 1 | 2017 | 2105 | 0.02 | Why? |
Clinical Competence | 1 | 2018 | 3263 | 0.02 | Why? |
Receptors, Leptin | 1 | 2002 | 12 | 0.02 | Why? |
Models, Statistical | 1 | 2021 | 5312 | 0.02 | Why? |
Hand Hygiene | 1 | 2014 | 1493 | 0.02 | Why? |
Phytohemagglutinins | 1 | 2002 | 15 | 0.02 | Why? |
Concanavalin A | 1 | 2002 | 19 | 0.02 | Why? |
Heart Valve Prosthesis | 1 | 2009 | 533 | 0.02 | Why? |
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.02 | Why? |
Heart Valve Prosthesis Implantation | 1 | 2009 | 552 | 0.01 | Why? |
Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
Length of Stay | 1 | 2019 | 11042 | 0.01 | Why? |
Attitude of Health Personnel | 1 | 2018 | 4741 | 0.01 | Why? |
Models, Theoretical | 1 | 2019 | 6659 | 0.01 | Why? |
Equipment Contamination | 1 | 2009 | 1308 | 0.01 | Why? |
Early Diagnosis | 1 | 2009 | 2443 | 0.01 | Why? |
Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Protein Processing, Post-Translational | 1 | 2002 | 634 | 0.01 | Why? |
Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
Phosphorylation | 1 | 2002 | 1060 | 0.01 | Why? |
Mice | 1 | 2017 | 21357 | 0.01 | Why? |
Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
HIV Infections | 1 | 2002 | 11620 | 0.01 | Why? |
Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
Recombinant Proteins | 1 | 2002 | 3786 | 0.01 | Why? |
Cells, Cultured | 1 | 2002 | 5835 | 0.01 | Why? |
Hepatitis C | 1 | 2002 | 1514 | 0.01 | Why? |
Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
RNA, Messenger | 1 | 2002 | 5131 | 0.01 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
Signal Transduction | 1 | 2002 | 7207 | 0.00 | Why? |
Child | 1 | 2002 | 70012 | 0.00 | Why? |